Quinn Opportunity Partners LLC Neuronetics, Inc. Transaction History

Quinn Opportunity Partners LLC

$939 Million
Q3 2024

A detailed history of Quinn Opportunity Partners LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 20,000 shares of STIM stock, worth $27,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,000

Previous 20,000 -0.0%

Holding current value

$27,799

Previous $36,000 58.33%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.73 - $4.81 $17,300 - $48,099	-10,000 Reduced 33.33%	20,000 $36,000
Q1 2024 May 14, 2024	SELL	$2.68 - $4.8 $178,680 - $320,025	-66,672 Reduced 68.97%	30,000 $142,000
Q4 2023 Feb 13, 2024	SELL	$1.05 - $2.9 $6,539 - $18,061	-6,228 Reduced 6.05%	96,672 $280,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $2.22 $132,741 - $228,438	102,900 New	102,900 $138,000
Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $15,700 - $31,133	-6,681 Reduced 24.01%	21,144 $67,000
Q2 2022 Aug 15, 2022	SELL	$2.09 - $3.71 $10,450 - $18,550	-5,000 Reduced 15.23%	27,825 $89,000
Q1 2022 May 16, 2022	BUY	$2.84 - $4.52 $93,223 - $148,369	32,825 New	32,825 $99,000
Q1 2021 May 13, 2021	SELL	$10.6 - $21.27 $1.17 Million - $2.36 Million	-110,763 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$4.95 - $11.45 $836,084 - $1.93 Million	-168,906 Reduced 60.39%	110,763 $1.23 Million
Q3 2020 Nov 16, 2020	SELL	$1.82 - $5.87 $395,122 - $1.27 Million	-217,100 Reduced 43.7%	279,669 $1.36 Million
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.61 $28,200 - $52,200	20,000 Added 4.19%	496,769 $959,000
Q1 2020 May 12, 2020	BUY	$1.28 - $4.5 $413,155 - $1.45 Million	322,778 Added 209.61%	476,769 $901,000
Q4 2019 Feb 13, 2020	BUY	$4.03 - $9.22 $620,583 - $1.42 Million	153,991 New	153,991 $691,000

Others Institutions Holding STIM

# of Institutions

Shares Held

13.1M

Call Options Held

30.1K

Put Options Held

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $37.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quinn Opportunity Partners LLC with notifications on news.

Account

Quinn Opportunity Partners LLC Neuronetics, Inc. Transaction History